GlassScriptPhysician profile
Alyssa Maida
NPI 1558889105
$3,075.92
in general payments reported to CMS, 2019-2025
15 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $806 · 2022: $793 · 2023: $786 · 2024: $590 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,476.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $601.96 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $564.56 | 2021-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $508.43 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $435.07 | 2022-2024 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $299.79 | 2021-2025 | Lifevest |
| Chiesi USA, INC. | $184.42 | 2021-2024 | Kengreal |
| Abbott Laboratories | $111.86 | 2021 | |
| Amgen INC. | $102.52 | 2021-2025 | Repatha, Repatha |
| Terumo Medical Corporation | $94.43 | 2021 | |
| Medtronic, INC. | $44.82 | 2024 | Symplicity G3, Onyx Frontier |
| Atricure, INC. | $34.07 | 2024 | |
| Pfizer INC. | $31.80 | 2023-2025 | |
| Boston Scientific Corporation | $24.74 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $19.46 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $17.99 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Maida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.